Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

December 11, 2019 | Daily News

The Congressional Progressive Caucus expressed optimism it would get at least one of its amendments added to House Speaker Nancy Pelosi’s drug pricing bill, following a meeting between caucus leaders and the California Democrat Tuesday afternoon (Dec.10).

December 10, 2019 | Daily News

All but $5 billion from the half a trillion dollars in overall savings from House Democrats’ drug pricing bill would be absorbed by new Medicare benefits for seniors and other investments, according to the final budget-impact projection by the Congressional Budget Office.

December 10, 2019 | Daily News

The Senate passed over-the-counter (OTC) drug monograph reform legislation by a vote of 91-2 on Tuesday (Dec. 10), coming after the lower chamber’s counterpart bill, reintroduced over the summer, was added to the House GOP’s drug pricing legislation.

December 10, 2019 | Daily News

The U.S. District Court of the District of Columbia ruled on Friday (Dec. 6) that FDA cannot regulate Genus Medical Technologies’ barium sulfate contrast agent as a drug because it qualifies as a medical device under the statute.

December 10, 2019 | Daily News

A top HHS official plugged the parallel review program between FDA and CMS as a key step to close what is sometimes a years-long gap between approval of new therapies and Medicare coverage decisions, and a CMS official said the agency hopes to better promote and support the program.

December 10, 2019 | Daily News

House Democrats on Tuesday unveiled new tweaks to the U.S.-Mexico-Canada Agreement, which include the removal of biologics exclusivity protections, and said a vote on an implementing bill could come as soon as next week.

December 09, 2019 | Daily News

The latest version of the Senate health committee’s drug pricing legislation no longer contains three key provisions: one that would give FDA new authority to address outdated drug labeling, another that would exempt biologic products from having to follow U.S. Pharmacopeial standards and a third that would stop brand drug makers from inappropriately using FDA citizen petitions to delay generic competition, based on a section-by-section of the bill released Monday (Dec. 9).

December 09, 2019 | Daily News

House Republicans on Monday (Dec. 9) introduced a bill (H.R. 19) that combines many bipartisan measures to control drug prices, including several from the Senate Finance bill, but it excludes a key measure from the upper chamber’s bill that would make drug companies pay back the government when they raise prices faster than inflation.

December 06, 2019 | Daily News

FDA on Thursday (Dec. 5) launched CURE ID, an internet-based application that will allow members of the clinical community to share their experiences in treating infectious diseases with novel uses of existing FDA-approved drugs.

December 06, 2019 | Daily News

Senate Finance Committee leaders will release an updated drug pricing bill on Friday (Dec. 5) less than 24 hours after House Speaker Nancy Pelosi (D-CA) announced the lower chamber will vote on her more-aggressive drug pricing bill next week.

December 06, 2019 | Daily News

Senate Finance Committee leaders will release an updated drug pricing bill on Friday (Dec. 5) less than 24 hours after House Speaker Nancy Pelosi (D-CA) announced the lower chamber will vote on her more-aggressive drug pricing bill next week.

December 06, 2019 | Daily News

Senate Finance Committee leaders will release an updated drug pricing bill on Friday (Dec. 5) less than 24 hours after House Speaker Nancy Pelosi (D-CA) announced the lower chamber will vote on her more-aggressive drug pricing bill next week.

December 06, 2019 | Daily News

Senate Finance Committee leaders will release an updated drug pricing bill on Friday (Dec. 5) less than 24 hours after House Speaker Nancy Pelosi (D-CA) announced the lower chamber will vote on her more-aggressive drug pricing bill next week.

December 05, 2019 | Daily News

The Congressional Budget Office estimates that House Democrats’ drug pricing bill would save half a trillion dollars in a decade, according to House Democratic leaders, and Democrats plan to use those savings to pay for additional drug research at the National Institutes of Health, additional Medicare benefits and a hodgepodge of Medicare and Medicaid policies that would lower costs for beneficiaries of those programs.

December 05, 2019 | Daily News

Retail prescription drug prices declined overall by 1% in 2018 but overall spending on retail prescription drugs increased by 2.5%, according to CMS’s National Health Expenditures survey, released on Thursday (Dec. 5).

December 05, 2019 | Daily News

Republican lawmakers on Wednesday expressed concern about reports the Trump administration is willing to give up language on protections for biologic drugs in the U.S.-Mexico-Canada Agreement, but one ardent supporter of strong data exclusivity provisions in trade deals suggested the move would not affect his support for USMCA.

December 05, 2019 | Daily News

The House will vote next week on legislation to let Medicare negotiate drug prices and make those prices available to people with private insurance.

December 05, 2019 | Daily News

Biopharmaceutical venture fund and managed care organization experts believe FDA should stay out of the medical product pricing and value arenas and instead let the marketplace determine value.

December 05, 2019 | Daily News

Rare disease advocates, gathered on Capitol Hill Wednesday (Dec. 4), made a plea for Congress and FDA to push policies aimed at spurring development of rare disease treatments.

December 03, 2019 | Daily News

The White House Council of Economic Advisers estimates that House Democrats’ drug pricing bill would thwart up to 100 drug inventions over a decade, compared to the eight to 15 fewer drugs that the nonpartisan Congressional Budget Office estimated would result from H.R. 3.

Pages